DOI: http://dx.doi.org/10.18203/2349-3933.ijam20213718

A case of Epstein-Barr virus presenting as spondyloarthritis

Mohan Varughese, Vishnu Chandran, Navya Mariam Koshy, Karol Sara Mathew

Abstract


Viral arthritis can be caused by various viruses such as parvovirus, alphavirus, rubella, hepatitis B, C and flavivirus. High titre of antibodies to Epstein-Barr virus (EBV) is present in rheumatoid arthritis (RA) patients. EBV, a member of the herpes virus family, is one among the most common human viruses. Vitamin D deficiency can worsen the prognosis in such patients. Abnormalities in innate and adaptive immune reactions in response to EBV infection were one of the complications observed in RA patients. It was a self-limiting infection with a 90% lifetime prevalence. On the other hand, spondyloarthritis was rarely associated with viral infections. A 35 year old male patient who had a history of TB, admitted through OP, with complaints of intermittent fever, joint pain, pain radiating from back to lower limbs. On investigation, the patient was found to be vitamin D deficient. Differential diagnosis such as TB with reactive arthritis, lymphoma and CMV infection were ruled out. MRI of the spine and pelvis confirmed spondylarthritis. The serology for EBV showed that the EBV IgM levels had increased by two-fold. The on-going inflammatory status was well-managed with NSAIDS, as there was low evidence for antiviral therapy. EBV infection presenting as spondyloarthritis is a very rare presentation and here we are discussing a case of spondylarthritis in a patient with infectious mononucleosis. The patients with fever, polyarthritis, lymphadenopathy and spondylarthritis are to be investigated for EBV infection along with the other cause of polyarthritis.


Keywords


Cytomegalovirus, Epstein-Barr virus, Rheumatoid arthritis, Spondyloarthritis

Full Text:

PDF

References


Olmos CM, Matilla MF, Villarino MR, Barrio IM, Sancho JJ. Joint Involvement secondary to Epstein-Barr virus. Reumatología Clínica. 2016;12(2):100-2.

Odumade OA, Hogquist KA, Balfour HH. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clinic Microbiol Rev. 2011;24(1):193-209.

Costenbader KH, Karlson EW. Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthr Res Ther. 2006;8(1):1-7.

Tiwari V, Bergman MJ. Viral arthritis. Treasure Island (FL): StatPearls Publishing; 2021.

Fox RI, Luppi M, Pisa P, Kang HI. Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis. J Rheumatol. 1992;32:18-24.

MSD Manual Consumer Version. Fact sheet: Infectious mononucleosis-infections, 2021 Available at: https://www.msdmanuals.com/home/infections /herpesvirus-infections/infectious-mononucleosis Acessed on 30 June 2021.

Ray CG, Gall EP, Minnich LL, Roediger J, DeBenedetti C, Corrigan JJ. Acute polyarthritis associated with active Epstein-Barr virus infection. JAMA. 1982;248(22):2990-3.

Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881-6.

Fernandez C, Beeching NJ. Pyrexia of unknown origin. Clin Med (Lond). 2018;18(2):170-4.

Tzellos S, Farrell PJ. Epstein-Barr virus sequence variation-biology and disease. Pathogens. 2012;1(2):156-74.

Kawabe A, Nakano K, Miyata H, Shibuya R, Matsuyama A, Ogoshi T, et al. Fatal chronic active epstein-barr virus infection in a rheumatoid arthritis patient treated with abatacept. Intern Med. 2019;58(4):585-91.

Roberts ML, Luxembourg AT, Cooper NR. Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infection. J Gen Virol. 1996;77(12):3077-85.

Febres-Aldana AJ, Febres-Aldana CA, Dvir K, Galarza-Fortuna G, Schwartz M, Medina AM, et al. Reactivation of Epstein–Barr virus presenting as massive splenomegaly after initiation of golimumab treatment. Case Rep Hematol. 2020.